Saudi hospital treats sickle cell disease with gene therapy

King Faisal Specialist Hospital & Research Centre in Saudi Arabia has successfully treated a patient with sickle cell disease using gene therapy. The treatment modified the patient's own stem cells to correct the genetic defect that causes the condition.

The procedure is part of a clinical trial designed to help patients who can't receive traditional stem cell transplants from donors. The hospital extracted the patient's blood-forming stem cells, fixed the genetic problem in a lab, then put the corrected cells back into the patient's body.

How did it work?

The gene therapy process involved several key steps:

• Doctors removed hematopoietic stem cells from the patient's bone marrow
• Laboratory technicians modified these cells to correct the sickle cell genetic defect
• The corrected cells were reinfused back into the patient
• The modified stem cells began producing healthy blood cells

This approach uses the patient's own genetic profile to create a personalized treatment. The hospital says this allows for more precise therapy tailored to each individual case.

Why does it matter?

Gene therapy addresses the root cause of sickle cell disease rather than just managing symptoms. This could significantly improve patients' daily lives in several ways:

• Fewer painful health crises
• Less need for regular blood transfusions
• Reduced hospital stays
• Better daily functioning and health stability
• Lower risk of long-term complications

The treatment is particularly important for patients who aren't eligible for donor stem cell transplants, which has been the main curative option for sickle cell disease.

The context

King Faisal Specialist Hospital has built a comprehensive program around gene therapy that combines patient care with research. The hospital says it follows strict safety and quality standards, with coordination between medical, research, and technical teams.

All procedures are done under oversight from health authorities and follow international standards. The hospital conducts thorough patient assessments and uses specialized treatment facilities.

The Saudi hospital has gained recognition in recent rankings. It placed first in the Middle East and North Africa region and 12th globally among the world's top 250 academic medical centers for 2026. Brand Finance 2025 named it the most valuable healthcare brand in the Kingdom and Middle East region.